UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017390
Receipt number R000020110
Scientific Title Effectiveness and safety examination of the JPS Hangekobokuto extract granule (for composition) for dysphagia and the after cardiac surgery
Date of disclosure of the study information 2015/05/02
Last modified on 2020/05/28 15:45:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness and safety examination of the JPS Hangekobokuto extract granule (for composition) for dysphagia and the after cardiac surgery

Acronym

Hangekobokuto study

Scientific Title

Effectiveness and safety examination of the JPS Hangekobokuto extract granule (for composition) for dysphagia and the after cardiac surgery

Scientific Title:Acronym

Hangekobokuto study

Region

Japan


Condition

Condition

Patient after the cardiac operation

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether the administration of hangekobokuto for 2 weeks after cardiac surgery decreases the incidence of swallowing disorder.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Swallowing reflex test

Key secondary outcomes

coughing reflection test
Substance P quantitative examination in saliva
Aspiration pneumonia incidence rate
Amount of antibiotic


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

lactose(placebo) 7.5g/day 14days

Interventions/Control_2

JPS hange-kobokuto extract granule(for composition) 7.5g/day 14days

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who will undergo cardiac surgery (including a sternal midline incision procedure) as a scheduled surgery in the Department of Cardiovascular Surgery at our hospital.
1) Men and women over 20 years old who can orally ingest hangekobokuto
2) Patients who received an explanation of the objective and content of this research, and in whom voluntary consent could be obtained

Key exclusion criteria

1) Patients undergoing developing drug administration or patients scheduled for developing drug administration
2) Patients who are pregnant or who want to become pregnant during the study observation period, as well as patients who are lactating
3) Patients who are taking or are scheduled to take other kampo medicines
4) Patients with Parkinson's disease and cerebral infarction, and those who are prone to develop aspiration pneumonitis.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Koji
Middle name
Last name Kawago

Organization

Tokyo Medical University Hachioji Medical Center

Division name

Cardiovascular surgery

Zip code

193-0998

Address

1163, Tachimachi, Hachioji-shi, Tokyo

TEL

042-665-5611

Email

kkawago@tokyo-med.ac.jp


Public contact

Name of contact person

1st name Koji
Middle name
Last name Kawago

Organization

Tokyo Medical University Hachioji Medical Center

Division name

Cardiovascular surgery

Zip code

193-0998

Address

1163, Tachimachi, Hachioji-shi, Tokyo

TEL

042-665-5611

Homepage URL


Email

kkawago@tokyo-med.ac.jp


Sponsor or person

Institute

Tokyo Medical University Hachioji Medical Center Cardiovascular surgery

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical University Hachioji Medical Center Cardiovascular surgery

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical University Hachioji Medical Center IRB

Address

1163, Tachimachi, Hachioji-shi, Tokyo

Tel

042-665-5611

Email

h-somu@tokyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科大学八王子医療センター


Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 02 Day


Related information

URL releasing protocol

https://doi.org/10.5761/atcs.oa.19-00128

Publication of results

Unpublished


Result

URL related to results and publications

https://doi.org/10.5761/atcs.oa.19-00128

Number of participants that the trial has enrolled

34

Results

The rate of subjects with postoperative aspiration pneumonia was significantly lower in the HKT group than in the placebo group (p = 0.017).

Results date posted

2020 Year 05 Month 28 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Consecutive patients undergoing cardiovascular surgery at the Department of Cardiovascular Surgery of Tokyo Medical University Hachioji Medical Center between August 2014 and August 2015

Participant flow

All patients provided written informed consent.

Adverse events

n.p

Outcome measures

The primary endpoint was prevention of postoperative aspiration pneumonia.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2014 Year 07 Month 01 Day

Date of IRB

2014 Year 07 Month 25 Day

Anticipated trial start date

2014 Year 08 Month 01 Day

Last follow-up date

2015 Year 09 Month 30 Day

Date of closure to data entry

2015 Year 09 Month 30 Day

Date trial data considered complete

2015 Year 09 Month 30 Day

Date analysis concluded

2017 Year 08 Month 30 Day


Other

Other related information



Management information

Registered date

2015 Year 05 Month 02 Day

Last modified on

2020 Year 05 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020110


Research Plan
Registered date File name
2018/06/25 半夏厚朴湯試験デザインP.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name